Effectiveness Trial on Alleviation of Infant Malnutrition With Fortified Spread or Maize-Soy Flour Food Supplements
LCNI-7. A Three-centre Intervention Trial in Rural Malawi, Testing the Effectiveness of Fortified Spread or Maize-Soy Flour Supplementation to Alleviate Moderate Malnutrition Among 6-18 Month Old Children
1 other identifier
interventional
299
1 country
1
Brief Summary
This study tests the hypothesis that moderately underweight but not severely wasted 6-17-month old infants receiving fortified spread or maize-spy flour as a food supplement for 12 weeks grow better during the supplementation than infants who do not get any food supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Nov 2007
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2007
CompletedFirst Posted
Study publicly available on registry
January 11, 2007
CompletedStudy Start
First participant enrolled
November 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedDecember 4, 2015
December 1, 2015
6 months
January 10, 2007
December 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight gain during the 12-week follow-up (in grams)
12 weeks
Secondary Outcomes (5)
Length gain during the 12-week follow-up (in centimetres
12 weeks
Change in blood haemoglobin concentration during the study period (g/l)
12 weeks
Change in anthropometric indices (WAZ, WHZ and HAZ)
12 weeks
Proportion developing moderate or severe wasting during the intervention (WHM<80% of the reference mean)
12 weeks
Change in mid-upper arm and head circumference
12 weeks
Study Arms (3)
Control
NO INTERVENTIONLNS
EXPERIMENTALLipid-based nutrient supplement
CSB
EXPERIMENTALCorn-soy blend supplement
Interventions
Eligibility Criteria
You may qualify if:
- signed informed consent from at least one guardian
- age 6.00 months to 14.99 months
- weight-for-age \<-2.0 Z scores
- availability during the period of the study
- permanent resident Lungwena Health Centre catchment area
You may not qualify if:
- moderate or severe wasting (WHM\<80% of the reference median)
- history of peanut allergy
- history of any serious allergic reaction to any substance, requiring emergency medical care
- history of anaphylaxis
- severe illness warranting hospital referral
- concurrent participation in another clinical trial with intervention to the child
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Medicine, University of Malawi
Mangochi, Mangochi District, Malawi
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Per Ashorn, MD, PhD
University of Tampere, Medical School, Finland
- PRINCIPAL INVESTIGATOR
Kenneth Maleta, MBBS, PhD
University of Malawi, College of Medicine, Department of Community Health
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PROFESSOR OF PEDIATRICS
Study Record Dates
First Submitted
January 10, 2007
First Posted
January 11, 2007
Study Start
November 1, 2007
Primary Completion
May 1, 2008
Study Completion
May 1, 2008
Last Updated
December 4, 2015
Record last verified: 2015-12